what does tirzepatide do to the brain for Weight Loss (Fat Loss) What to Expect After Starting
Description
The findings suggest that semaglutide users experienced a "significantly lower risk for medical encounters" related to tobacco use disorder (TUD)
Compounded medications are not FDA-approved and do not have equivalent clinical trial data establishing the same safety, efficacy, or outcomes
Patients should always seek professional medical advice before starting or adjusting any medication
Wegovy is a GLP-1 receptor agonist, while Mounjaro targets both GLP-1 and GIP receptors, which may offer added benefits for some individuals
